Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Neurobiol Aging ; 36(5): 1890-902, 2015 May.
Article in English | MEDLINE | ID: mdl-25771393

ABSTRACT

We have investigated the relevance of d-aspartate oxidase, the only enzyme known to selectively degrade d-aspartate (d-Asp), in modulating glutamatergic system homeostasis. Interestingly, the lack of the Ddo gene, by raising d-Asp content, induces a substantial increase in extracellular glutamate (Glu) levels in Ddo-mutant brains. Consistent with an exaggerated and persistent N-methyl-d-aspartate receptor (NMDAR) stimulation, we documented in Ddo knockouts severe age-dependent structural and functional alterations mirrored by expression of active caspases 3 and 7 along with appearance of dystrophic microglia and reactive astrocytes. In addition, prolonged elevation of d-Asp triggered in mutants alterations of NMDAR-dependent synaptic plasticity associated to reduction of hippocampal GluN1 and GluN2B subunits selectively located at synaptic sites and to increase in the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-to-N-methyl-d-aspartate ratio. These effects, all of which converged on a progressive hyporesponsiveness at NMDAR sites, functionally resulted in a greater vulnerability to phencyclidine-induced prepulse inhibition deficits in mutants. In conclusion, our results indicate that d-aspartate oxidase, by strictly regulating d-Asp levels, impacts on the homeostasis of glutamatergic system, thus preventing accelerated neurodegenerative processes.


Subject(s)
D-Aspartate Oxidase/physiology , Glutamates/metabolism , Homeostasis/genetics , Mutation , Animals , Astrocytes/pathology , Caspase 3/metabolism , Caspase 7/metabolism , D-Aspartate Oxidase/genetics , D-Aspartic Acid/metabolism , Mice, Knockout , Microglia/pathology , Neurodegenerative Diseases/etiology , Neurodegenerative Diseases/prevention & control , Neuronal Plasticity/genetics , Receptors, N-Methyl-D-Aspartate/metabolism
2.
Transl Psychiatry ; 4: e417, 2014 Jul 29.
Article in English | MEDLINE | ID: mdl-25072322

ABSTRACT

D-aspartate (D-Asp) is an atypical amino acid, which is especially abundant in the developing mammalian brain, and can bind to and activate N-methyl-D-Aspartate receptors (NMDARs). In line with its pharmacological features, we find that mice chronically treated with D-Asp show enhanced NMDAR-mediated miniature excitatory postsynaptic currents and basal cerebral blood volume in fronto-hippocampal areas. In addition, we show that both chronic administration of D-Asp and deletion of the gene coding for the catabolic enzyme D-aspartate oxidase (DDO) trigger plastic modifications of neuronal cytoarchitecture in the prefrontal cortex and CA1 subfield of the hippocampus and promote a cytochalasin D-sensitive form of synaptic plasticity in adult mouse brains. To translate these findings in humans and consistent with the experiments using Ddo gene targeting in animals, we performed a hierarchical stepwise translational genetic approach. Specifically, we investigated the association of variation in the gene coding for DDO with complex human prefrontal phenotypes. We demonstrate that genetic variation predicting reduced expression of DDO in postmortem human prefrontal cortex is mapped on greater prefrontal gray matter and activity during working memory as measured with MRI. In conclusion our results identify novel NMDAR-dependent effects of D-Asp on plasticity and physiology in rodents, which also map to prefrontal phenotypes in humans.


Subject(s)
Brain/physiology , D-Aspartic Acid/physiology , Gray Matter/physiology , Neuronal Plasticity/physiology , Receptors, N-Methyl-D-Aspartate/physiology , Adult , Animals , Brain/pathology , D-Aspartate Oxidase/genetics , D-Aspartate Oxidase/physiology , Female , Gene Deletion , Gene Expression Regulation, Enzymologic/genetics , Gray Matter/pathology , Hippocampus/pathology , Hippocampus/physiology , Humans , Magnetic Resonance Imaging , Male , Memory, Short-Term/physiology , Mice , Mice, Inbred C57BL , Neuronal Plasticity/genetics , Organ Size/genetics , Organ Size/physiology , Phenotype , Polymorphism, Single Nucleotide/genetics , Prefrontal Cortex/pathology , Prefrontal Cortex/physiology , Protein Biosynthesis/genetics , RNA, Messenger/genetics
3.
Mol Cell Biol ; 32(10): 1967-83, 2012 May.
Article in English | MEDLINE | ID: mdl-22393259

ABSTRACT

Recent investigations have shown that a variety of D-amino acids are present in living organisms and that they possibly play important roles in physiological functions in the body. D-Amino acid oxidase (DAO) and D-aspartate oxidase (DDO) are degradative enzymes stereospecific for D-amino acids. They have been identified in various organisms, including mammals and the nematode Caenorhabditis elegans, although the significance of these enzymes and the relevant functions of D-amino acids remain to be elucidated. In this study, we investigated the spatiotemporal localization of C. elegans DAO and DDOs (DDO-1, DDO-2, and DDO-3) and measured the levels of several D- and L-amino acids in wild-type C. elegans and four mutants in which each gene for DAO and the DDOs was partially deleted and thereby inactivated. Furthermore, several phenotypes of these mutant strains were characterized. The results reported in this study indicate that C. elegans DAO and DDOs are involved in egg-laying events and the early development of C. elegans. In particular, DDOs appear to play important roles in the development and maturation of germ cells. This work provides novel and useful insights into the physiological functions of these enzymes and D-amino acids in multicellular organisms.


Subject(s)
Caenorhabditis elegans Proteins/physiology , Caenorhabditis elegans/enzymology , D-Amino-Acid Oxidase/physiology , D-Aspartate Oxidase/physiology , Animals , Caenorhabditis elegans/embryology , Embryo, Nonmammalian/enzymology , Female , Mutation , Oviparity/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...